Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds

Optimization of tumor xenograft dissociation for the profiling of cell surface markers and nutrient transporters

(2013) Vincent Petit et al.   LABORATORY INVESTIGATION

Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells

(2013) Y.-J. Liang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting Bacterial Toxins

(2012) Mattias E. Ivarsson et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers

(2012) Che Lin et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer

(2012) Ali I. Shamseddine et al.   CHEMOTHERAPY

Discrepancies between primary tumor and metastasis: A literature review on clinically established biomarkers

(2012) Stéphane Vignot et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

The role of chemotherapy and targeted agents in patients with metastatic breast cancer

(2011) Stephen R.D. Johnston   EUROPEAN JOURNAL OF CANCER

Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

(2011) Naoki Niikura et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor-Specific Targeting of Pancreatic Cancer with Shiga Toxin B-Subunit

(2011) M. Maak et al.   MOLECULAR CANCER THERAPEUTICS

Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation

(2010) L de Plater et al.   BRITISH JOURNAL OF CANCER

Biochemical, pathological and oncological relevance of Gb3Cer receptor

(2010) D. Đevenica et al.   MEDICAL ONCOLOGY

Shiga toxin and its use in targeted cancer therapy and imaging

(2010) Nikolai Engedal et al.   Microbial Biotechnology

Expression of verotoxin-1 receptor Gb3 in breast cancer tissue and verotoxin-1 signal transduction to apoptosis

(2009) David Johansson et al.   BMC CANCER

Cisplatin-induced expression of Gb3 enables verotoxin-1 treatment of cisplatin resistance in malignant pleural mesothelioma cells

(2009) D Johansson et al.   BRITISH JOURNAL OF CANCER

Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression

(2009) Ivan O. Potapenko et al.   Molecular Oncology

Shiga Toxin Receptor Gb3Cer/CD77: Tumor-Association and Promising Therapeutic Target in Pancreas and Colon Cancer

(2009) Ute Distler et al.   PLoS One

Tracing the Retrograde Route in Protein Trafficking

(2008) Ludger Johannes et al.   CELL

Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool

(2008) T. Falguieres et al.   MOLECULAR CANCER THERAPEUTICS

Efficient antiproliferative and antiangiogenic effects on human ovarian cancer growth by gene transfer of attenuated mutants of Shiga-like toxin I

(2007) F. WEI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER